Affiliation:
1. Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur 425405, India
Abstract
Four different simple, accurate and precise UV-spectrophotometric methods have been developed for the estimation of palbociclib (PB) in bulk and in-house capsule dosage form by zero order (Method I), zero order AUC (Method II), ‘first order derivative UV-spectrophotometric (Method III), and first order AUC (Method IV) methods. The drug was dissolved in methanol (AR-Grade) and further dilution was made in double distilled water. Zero order was performed at λ max 220.00 nm of PB (Method I) and AUC was calculated between 215.40 nm - 228.20 nm wavelength (Method II). In Method-III zero-order spectra were derivatized into first-order and amplitude measured at 231.00 nm and the AUC was recorded between 224.00 nm - 240.60 nm (Method IV). PB followed linearity in the concentration range of 4.08-20.40 µg/mL with correlation coefficient (r2 )> 0.99 for PB.
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference22 articles.
1. 1) Pernas S., Tolaney S. M., Winer E. P. and Goel S.: CDK4/6 inhibition in breast cancer: current practice and future directions, Ther. Adv. Med. Oncol., 2018, 10, 1-15
2. 2) Schettini F., De Santo I., Rea C. G., De Placido P., Formisano L., Giuliano M., Arpino G., De Laurentiis M., Puglisi F., De Placido S. and Del Mastro L.: CDK 4/6 inhibitors as single agent in advanced solid tumors, Front. Oncol., 2018, 8, 608.
3. 3) Steger G. G., Gnant M. and Bartsch R.: Palbociclib for the treatment of postmenopausal breast cancer–an update, Expert Opin. Pharmacother., 2016, 17(2), 255-263.
4. 4) Dange Y., Bhinge S. and Salunkhe V.: Optimization and validation of RP-HPLC method for simultaneous estimation of palbociclib and letrozole, Toxicol. Mech. Methods, 2018, 28(3), 187-194.
5. 5) Kallepalli P.: New stability-indicating liquid chromatographic method for determination of palbociclib (an anti-breast cancer drug), Int. J. Green Pharm., 2018, 12(01), 270-275.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献